Auden Mckenzie, Advanz Pharma, others overturn UK CMA fines over hydrocortisone market behavior
Auden Mckenzie, Advanz Pharma and other drugmakers have overturned fines imposed by the UK Competition and Markets Authority over their behavior in the market for hydrocortisone tablets. In a ruling today,...To view the full article, register now.
Already a subscriber? Click here to view full article